BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 37064131)

  • 21. Proton Therapy in Non-small Cell Lung Cancer.
    Mesko S; Gomez D
    Curr Treat Options Oncol; 2018 Nov; 19(12):76. PubMed ID: 30483900
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proton arc reduces range uncertainty effects and improves conformality compared with photon volumetric modulated arc therapy in stereotactic body radiation therapy for non-small cell lung cancer.
    Seco J; Gu G; Marcelos T; Kooy H; Willers H
    Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):188-94. PubMed ID: 23920395
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost effectiveness of proton versus photon radiation therapy with respect to the risk of growth hormone deficiency in children.
    Mailhot Vega R; Kim J; Hollander A; Hattangadi-Gluth J; Michalski J; Tarbell NJ; Yock TI; Bussiere M; MacDonald SM
    Cancer; 2015 May; 121(10):1694-702. PubMed ID: 25641407
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proton therapy for locally advanced non-small cell lung cancer.
    Gjyshi O; Liao Z
    Br J Radiol; 2020 Mar; 93(1107):20190378. PubMed ID: 31430188
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proton beams to replace photon beams in radical dose treatments.
    Suit H; Goldberg S; Niemierko A; Trofimov A; Adams J; Paganetti H; Chen GT; Bortfeld T; Rosenthal S; Loeffler J; Delaney T
    Acta Oncol; 2003; 42(8):800-8. PubMed ID: 14968940
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantification of Acute Skin Toxicities in Patients With Breast Cancer Undergoing Adjuvant Proton versus Photon Radiation Therapy: A Single Institutional Experience.
    DeCesaris CM; Rice SR; Bentzen SM; Jatczak J; Mishra MV; Nichols EM
    Int J Radiat Oncol Biol Phys; 2019 Aug; 104(5):1084-1090. PubMed ID: 31028831
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Quantitative Clinical Decision-Support Strategy Identifying Which Patients With Oropharyngeal Head and Neck Cancer May Benefit the Most From Proton Radiation Therapy.
    Brodin NP; Kabarriti R; Pankuch M; Schechter CB; Gondi V; Kalnicki S; Guha C; Garg MK; Tomé WA
    Int J Radiat Oncol Biol Phys; 2019 Jul; 104(3):540-552. PubMed ID: 30496877
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proton beams in cancer treatments: Clinical outcomes and dosimetric comparisons with photon therapy.
    Doyen J; Falk AT; Floquet V; Hérault J; Hannoun-Lévi JM
    Cancer Treat Rev; 2016 Feb; 43():104-12. PubMed ID: 26827698
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radiation biology considerations of proton therapy for gastrointestinal cancers.
    Beltran C; Schultz HL; Anand A; Merrell K
    J Gastrointest Oncol; 2020 Feb; 11(1):225-230. PubMed ID: 32175125
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recent advances in intensity modulated radiotherapy and proton therapy for esophageal cancer.
    Xi M; Lin SH
    Expert Rev Anticancer Ther; 2017 Jul; 17(7):635-646. PubMed ID: 28503964
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-dose Intensity-modulated proton therapy versus Standard-dose Intensity-modulated RadIation therapy for esophageal squamous cell carcinoma (HI-SIRI): study protocol for a randomized controlled clinical trial.
    Lertbutsayanukul C; Kitpanit S; Kannarunimit D; Chakkabat C; Oonsiri S; Thephamongkhol K; Puataweepong P; Katanyoo K; Sukhaboon J; Tovanabut C; Chongsathientham S; Treeratsapanich P; Soonthornrak J; Prayongrat A
    Trials; 2022 Oct; 23(1):897. PubMed ID: 36273186
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Head and neck proton therapy in France: A missed opportunity or a challenge in front of us?
    Thariat J; Calugaru V; Aloi D; Maingon P; Grégoire V
    Cancer Radiother; 2021 Oct; 25(6-7):537-544. PubMed ID: 34272183
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dosimetry, Efficacy, Safety, and Cost-Effectiveness of Proton Therapy for Non-Small Cell Lung Cancer.
    Qiu B; Men Y; Wang J; Hui Z
    Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative Effectiveness of Proton Therapy versus Photon Radiotherapy in Adolescents and Young Adults for Classical Hodgkin Lymphoma.
    Bates JE; Terezakis S; Morris CG; Rao AD; Sehgal S; Kumar R; Mailhot Vega RB; Mendenhall NP; Hoppe BS
    Int J Part Ther; 2022; 8(3):21-27. PubMed ID: 35127972
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current status and application of proton therapy for esophageal cancer.
    Wang X; Hobbs B; Gandhi SJ; Muijs CT; Langendijk JA; Lin SH
    Radiother Oncol; 2021 Nov; 164():27-36. PubMed ID: 34534613
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radiation-induced brain injury in patients with meningioma treated with proton or photon therapy.
    Song J; Aljabab S; Abduljabbar L; Tseng YD; Rockhill JK; Fink JR; Chang L; Halasz LM
    J Neurooncol; 2021 May; 153(1):169-180. PubMed ID: 33886111
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative Effectiveness of Proton vs Photon Therapy as Part of Concurrent Chemoradiotherapy for Locally Advanced Cancer.
    Baumann BC; Mitra N; Harton JG; Xiao Y; Wojcieszynski AP; Gabriel PE; Zhong H; Geng H; Doucette A; Wei J; O'Dwyer PJ; Bekelman JE; Metz JM
    JAMA Oncol; 2020 Feb; 6(2):237-246. PubMed ID: 31876914
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Investigating survival, quality of life and cognition in PROton versus photon therapy for
    Heggebø LC; Borgen IMH; Rylander H; Kiserud C; Nordenmark TH; Hellebust TP; Evensen ME; Gustavsson M; Ramberg C; Sprauten M; Magelssen H; Blakstad H; Moorthy J; Andersson K; Raunert I; Henry T; Moe C; Granlund C; Goplen D; Brekke J; Johannessen TA; Solheim TS; Marienhagen K; Humberset Ø; Bergström P; Agrup M; Dahl L; Gubanski M; Gojon H; Brahme CJ; Rydén I; Jakola AS; Vik-Mo EO; Lie HC; Asphaug L; Hervani M; Kristensen I; Rueegg CS; Olsen IC; Ledal RJ; Degsell E; Werlenius K; Blomstrand M; Brandal P
    BMJ Open; 2023 Mar; 13(3):e070071. PubMed ID: 36940951
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence of second malignancies among patients treated with proton versus photon radiation.
    Chung CS; Yock TI; Nelson K; Xu Y; Keating NL; Tarbell NJ
    Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):46-52. PubMed ID: 23778197
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.